We are live on ! Find out more
LBPS

4D Pharma PLC
LBPS

Delisted

LBPS was delisted on the 24th of June, 2022.

Back to rankings

6 hedge funds and large institutions have $2.12M invested in 4D Pharma PLC in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 4 → 6 (+2)

11% less capital invested

Capital invested by funds: $2.38M → $2.12M (-$260K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KC
Kepos Capital
New York
+$1.16M
2
WAM
Wolverine Asset Management
Illinois
+$75.1K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$115K
2
Osaic Holdings
Osaic Holdings
Arizona
-$22.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
RL
1
Ruffer LLP
United Kingdom
$1.2M – – –
KC
2
Kepos Capital
New York
$795K +$1.16M +129,000 New
Morgan Stanley
3
Morgan Stanley
New York
$54K -$115K -12,812 -59%
WAM
4
Wolverine Asset Management
Illinois
$51K +$75.1K +8,349 New
Osaic Holdings
5
Osaic Holdings
Arizona
$9K -$22.9K -2,549 -64%
UBS Group
6
UBS Group
Switzerland
$6K – – –

LBPS Hedge Fund Activity: Q3 2021 in Review

6 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC (LBPS) for Q3 2021, worth a combined $2.12M — down 11% from $2.38M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new LBPS positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was Kepos Capital, opening a new position worth an estimated $1.16M. The largest seller was Morgan Stanley, cutting an estimated $115K.

  • 6 institutional investors held 4D Pharma PLC (LBPS) as of Q3 2021, up from 4 in Q2 2021.
  • Funds reported $2.12M of 4D Pharma PLC stock for Q3 2021, down 11% quarter-over-quarter.
  • 2 funds opened new 4D Pharma PLC positions in Q3 2021 and 0 closed out, a net change of +2 holders.
  • The largest 4D Pharma PLC buyer in Q3 2021 was Kepos Capital, an estimated $1.16M added.
  • The largest 4D Pharma PLC seller in Q3 2021 was Morgan Stanley, an estimated $115K sold.

Based on aggregated 13F filings for Q3 2021.